Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Immix Biopharma, Inc. (IMMX) had Pre-Tax Income of $-7.58M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.59M |
|
-- |
|
-- |
|
$7.66M |
|
$-7.66M |
|
$0.08M |
|
|
Pre-Tax Income |
$-7.58M |
$-7.58M |
|
$-7.59M |
|
$-7.59M |
|
$-7.59M |
|
$-7.59M |
|
$-7.66M |
|
$-7.53M |
|
31.93M |
|
31.93M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$16.58M |
|
$2.36M |
|
$3.50M |
|
$20.08M |
|
$10.85M |
|
-- |
|
$0.97M |
|
$11.82M |
|
$8.27M |
|
$8.27M |
|
$8.27M |
|
33.04M |
|
| Cash Flow Statement Financials | |
$-12.90M |
|
$-0.57M |
|
$11.72M |
|
$17.68M |
|
$15.95M |
|
$-1.73M |
|
$1.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.78% |
|
-91.78% |
|
-37.78% |
|
-91.78% |
|
$0.25 |
|
$-0.42 |
|
$-0.40 |
|